APA (7th ed.) Citation

Yang, J., Zhou, P., Yu, M., & Zhang, Y. (2021, May). Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Yang, Jiangping, Ping Zhou, Min Yu, and Yan Zhang. "Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer." Frontiers in Oncology May. 2021.

MLA (9th ed.) Citation

Yang, Jiangping, et al. "Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer." Frontiers in Oncology, May. 2021.